| Literature DB >> 35115902 |
S Karthikeyan1, G Ramkumar2, S Aravindkumar3, M Tamilselvi4, S Ramesh5, A Ranjith6.
Abstract
Currently, countries across the world are suffering from a prominent viral infection called COVID-19. Most countries are still facing several issues due to this disease, which has resulted in several fatalities. The first COVID-19 wave caused devastation across the world owing to its virulence and led to a massive loss in human lives, impacting the country's economy drastically. A dangerous disease called mucormycosis was discovered worldwide during the second COVID-19 wave, in 2021, which lasted from April to July. The mucormycosis disease is commonly known as "black fungus," which belongs to the fungus family Mucorales. It is usually a rare disease, but the level of destruction caused by the disease is vast and unpredictable. This disease mainly targets people already suffering from other diseases and consuming heavy medication to counter the disease they are suffering from. This is because of the reduction in antibodies in the affected people. Therefore, the patient's body does not have the ability to act against fungus-oriented infections. This black fungus is more commonly identified in patients with coronavirus disease in certain country. The condition frequently manifests on skin, but it can also harm organs such as eyes and brain. This study intends to design a modified neural network logic for an artificial intelligence (AI) strategy with learning principles, called a hybrid learning-based neural network classifier (HLNNC). The proposed method is based on well-known techniques such as convolutional neural network (CNN) and support vector machine (SVM). This article discusses a dataset containing several eye photographs of patients with and without black fungus infection. These images were collected from the real-time records of people afflicted with COVID followed by the black fungus. This proposed HLNNC scheme identifies the black fungus disease based on the following image processing procedures: image acquisition, preprocessing, feature extraction, and classification; these procedures were performed considering the dataset training and testing principles with proper performance analysis. The results of the procedure are provided in a graphical format with the precise specification, and the efficacy of the proposed method is established.Entities:
Mesh:
Year: 2022 PMID: 35115902 PMCID: PMC8793349 DOI: 10.1155/2022/4352730
Source DB: PubMed Journal: Contrast Media Mol Imaging ISSN: 1555-4309 Impact factor: 3.161
Figure 1(a) Infected eye with redness indication [6] and (b) mucormycosis.
Figure 2Dataset image samples of both normal fungus and normal images.
Cases of mucormycosis in India [10].
| State | Number of mucormycosis cases |
|---|---|
| Gujarat | 2281 |
| Maharashtra | 2000 |
| Andhra Pradesh | 910 |
| Madhya Pradesh | 720 |
| Rajasthan | 700 |
| Karnataka | 500 |
| Telangana | 350 |
| Haryana | 250 |
| Delhi | 197 |
| Uttar Pradesh | 112 |
| Punjab | 95 |
| Chhattisgarh | 87 |
| Bihar | 56 |
| Tamil Nadu | 40 |
| Kerala | 36 |
Requirement of amphotericin [11].
| State | Patients under treatment | No. of vials required per day | Total no. of vials needed for treatment (in lakhs) |
|---|---|---|---|
| Gujarat | 2859 | 17154 | 7.14 |
| Maharashtra | 2770 | 16620 | 6.93 |
| Andhra Pradesh | 766 | 4596 | 1,92 |
| Madhya Pradesh | 752 | 4512 | 1.88 |
| Telangana | 744 | 4464 | 1.86 |
| Uttar Pradesh | 701 | 4206 | 1.75 |
| Rajasthan | 492 | 2952 | 1.23 |
| Karnataka | 481 | 2886 | 1.20 |
| Haryana | 436 | 2616 | 1.09 |
| Tamil Nadu | 236 | 1416 | 0.59 |
| Bihar | 215 | 1290 | 0.54 |
| Punjab | 141 | 846 | 0.35 |
| Uttarakhand | 124 | 744 | 0.31 |
| Delhi | 119 | 714 | 0.30 |
| Chhattisgarh | 103 | 618 | 0.26 |
| Others | 184 | 1104 | 0.46 |
Algorithm 1Image acquisition and preprocessing.
Algorithm 2Extracting image features.
Figure 3Image variations used for classification.
Algorithm 3Classification.
Figure 4(a) Normal image and (b) diseased image.
Figure 5(a) Preprocessed normal images and (b) preprocessed disease images.
Figure 6Confusion matrix.
Figure 7(a) Training accuracy and (b) testing accuracy.
Figure 8(a) Training loss ratio and (b) testing loss ratio.
Figure 9Accuracy evaluation.